Songbo Zhao

Effects of CSF1R-targeted chimeric antigen receptor-modified NK92MI & T cells on tumor-associated macrophages.

Ping Zhang, Siyi Hu, Xingding Zhang, 2018, Immunotherapy.

Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells

Lifen Gao, Chunhong Ma, Xiaohong Liang, 2021, Journal for ImmunoTherapy of Cancer.

Concomitant Use of CD138- and CD19-directed Chimeric Antigen Receptor-modified T Cells Enhances Cytotoxicity Towards Multiple Myeloma

Lin Yang, Zixuan Li, Gangli An, 2021, Journal of Cancer Treatment and Research.

Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages.

Xuetian Yue, Zhuanchang Wu, Liyuan Wang, 2022, Cell reports.

Surface specifically modified NK-92 cells with CD56 antibody conjugated superparamagnetic Fe3O4 nanoparticles for magnetic targeting immunotherapy of solid tumors.

Lin Han, Lifen Gao, Chunhong Ma, 2021, Nanoscale.

The research significance of concomitant use of CAR-CD138-NK and CAR-CD19-NK to target multiple myelomas

Lin Yang, Gangli An, Huimin Meng, 2018 .

The hepatic GABAergic system promotes liver macrophage M2 polarization and mediates HBV replication in mice.

Yunxiao Wu, Y. Chen, Liyuan Wang, 2023, Antiviral research.

Immune function assessing of TIM3/CD28‐modified CD19 CAR‐T cells and general CD19 CAR‐T cells through a high‐throughput single‐cell microarray platform

Lifen Gao, Xiaohong Liang, Lin Han, 2024, Interdisciplinary Medicine.